Beta-blockers will continue to fall out of favor for hypertension

Beta-blockers will continue to fall out of favor for hypertension...especially atenolol.

Beta-blockers seem to prevent fewer CV events in patients with hypertension than other BP meds...despite similar BP lowering.

Atenolol has a particularly bad reputation...because most hypertension trials evaluating cardiovascular risk used atenolol.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote